| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $3,870,918 ) |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI174181 | Development and function of skin-resident innate-like T cells at early postnatal stages | 000 | 1 | NIH | 11/7/2023 | $427,881 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DE031352 | Evaluation of the Role of Macrophage Migratory Inhibitory Factor (MIF) in mediating Stem Cell Analgesia in a Model of Orofacial Pain | 000 | 2 | NIH | 11/29/2023 | $417,454 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA279681 | Function of the METTL3-NUP93 complex-mediated nuclear export of m6A-modified mRNAs in castration-resistant prostate cancer. | 000 | 1 | NIH | 11/27/2023 | $439,997 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA253678 | MnSOD-K68-Ac reprograms a lineage plasticity switch / stemness in ER+ breast malignancies | 001 | 4 | NIH | 11/30/2023 | $136,991 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA253678 | MnSOD-K68-Ac reprograms a lineage plasticity switch / stemness in ER+ breast malignancies | 000 | 4 | NIH | 11/20/2023 | $331,347 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA239227 | FoXM1 inhibition: a novel therapeutic avenue to treat breast cancers | 001 | 5 | NIH | 11/30/2023 | $9,121 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA239227 | FoXM1 inhibition: a novel therapeutic avenue to treat breast cancers | 000 | 5 | NIH | 11/29/2023 | $357,936 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DE031477 | Functional peripheral and central vagal neural circuits of interoception inhibiting pain | 000 | 3 | NIH | 11/30/2023 | $652,130 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R25NS115552 | Summer Physiology Undergraduate Researcher (SPUR) Program | 000 | 4 | NIH | 11/17/2023 | $107,680 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21CA286307 | Development of Caspase Cleavage Targeting Chimeras (CACTACs) for Targeted Protein Cleavage | 000 | 1 | NIH | 11/29/2023 | $192,844 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AI173816 | Novel animal models to study organ-specific SARS-CoV-2-induced pathology | 000 | 2 | NIH | 11/8/2023 | $198,563 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AI172207 | Translational Regulation of Candida glabrata Azole Resistance | 000 | 2 | NIH | 12/7/2023 | $209,250 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AG081709 | The role of medullary thymic epithelial cell-derived growth factors in regulating thymus growth and atrophy | 000 | 2 | NIH | 12/1/2023 | $174,375 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HL158081 | Role of BRD4 in Normal Hematopoiesis and Hematopoietic Stem Cell Biology | 000 | 3 | NIH | 11/24/2023 | $310,000 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | CE152902 | Community Project Funding/Congressionally Directed Spending - Construction | 01 | 1 | HRSA | 11/8/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | UH3DA048387 | Methocinnamox (MCAM): A novel ????-opioid receptor antagonist for opioid use disorders | 000 | 2 | NIH | 10/11/2023 | $20,389 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | CE152248 | Community Project Funding/Congressionally Directed Spending - Construction | 02 | 1 | HRSA | 11/16/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | CE152248 | Community Project Funding/Congressionally Directed Spending - Construction | 01 | 1 | HRSA | 11/8/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | T32AG021890 | Training Grant on the Biology of Aging | 000 | 20 | NIH | 10/24/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R25GM130437 | UTHealth-LINK- A PREP program | 001 | 4 | NIH | 10/31/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | K12GM111726 | San Antonio Biomedical Education and Research | 000 | 9 | NIH | 10/20/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R25GM130437 | UTHealth-LINK- A PREP program | 000 | 4 | NIH | 10/25/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | K01NS126489 | Delineating the role of the gut microbiota and its derived metabolites in the development of dementia in multi-ethnic populations | 000 | 1 | NIH | 12/4/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | UH3DA048387 | Methocinnamox (MCAM): A novel ????-opioid receptor antagonist for opioid use disorders | 001 | 2 | NIH | 11/8/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F31AI169993 | Molecular and cellular properties of broad and protective immune responses to the Plasmodium falciparum variant surface antigen responsible for severe malaria | 000 | 2 | NIH | 11/10/2023 | -$27,007 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | H4B15559 | Poison Control Stabilization and Enhancement Program | 01 | 15 | HRSA | 11/21/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | CE152902 | Community Project Funding/Congressionally Directed Spending - Construction | 03 | 1 | HRSA | 11/24/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | CE152902 | Community Project Funding/Congressionally Directed Spending - Construction | 02 | 1 | HRSA | 11/16/2023 | $0 |
| | 2024 | 2022 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | UG3DA048387 | Methocinnamox (MCAM): A novel ???-opioid receptor antagonist for opioid use disorders | 000 | 1 | NIH | 10/11/2023 | -$20,389 |
| | 2024 | 2022 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | UC2AR082195 | Comprehensive functional phenotyping of trigeminal neurons innervating temporomandibular joint (TMJ) tissues in male female and aged mice primates and humans with and without TMJ disorders (TMJD) | 000 | 1 | NIH | 10/24/2023 | $0 |
| | 2024 | 2022 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG064386 | Sex-specific determinants of early-phase recovery from skeletal muscle disuse. | 001 | 5 | NIH | 12/7/2023 | $476,317 |
| | 2024 | 2022 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AA025664 | Cognitive flexibility as a target for relapse prevention | 000 | 5 | NIH | 11/3/2023 | $0 |
| | 2024 | 2021 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK113816 | Purinergic regulation of ENaC in the distal nephron | 000 | 4 | NIH | 11/20/2023 | $0 |
| | 2024 | 2021 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01DK048514 | 5/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS)?Clinical Center | 000 | 28 | NIH | 10/27/2023 | -$31,949 |
| | 2024 | 2021 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DE026677 | Coupling activation of primary sensory neurons as a novel plasticity mechanism for chronic pain | 000 | 6 | NIH | 10/24/2023 | -$15,692 |
| | 2024 | 2021 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01DK048514 | 5/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS)?Clinical Center | 000 | 28 | NIH | 10/27/2023 | -$31,949 |
| | 2024 | 2021 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01DK048514 | 5/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS)?Clinical Center | 000 | 28 | NIH | 10/27/2023 | -$96,889 |
| | 2024 | 2021 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA048214 | Pharmacological and behavioral effects of MCAM: a long-acting, ? opioid receptor antagonist for treatment of opioid overdose and opioid abuse disorder | 000 | 3 | NIH | 11/17/2023 | $0 |
| | 2024 | 2021 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01DK048514 | 5/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS)?Clinical Center | 000 | 28 | NIH | 10/27/2023 | -$9,609 |
| | 2024 | 2021 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01DA045025 | Repurposing drugs in mixtures to treat drug abuse | 000 | 4 | NIH | 11/9/2023 | -$40,644 |
| | 2024 | 2021 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R25GM095480 | Recruiting and Retaining Underrepresented Students | 000 | 10 | NIH | 12/1/2023 | -$1,875 |
| | 2024 | 2021 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21CA245437 | Identify tumor suppressor driver genes of pancreatic ductal adenocarcinoma | 000 | 2 | NIH | 11/21/2023 | -$225 |
| | 2024 | 2020 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | TP1AH000206 | Replication of Programs Proven Effective throughout Bexar County and throughout Texas. | 02 | 2 | DHHS/OS | 11/28/2023 | -$12,670 |
| | 2024 | 2020 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI125701 | Mechanistic study of TGF-beta-dependent control of gut-resident memory T cells | 000 | 5 | NIH | 11/10/2023 | -$19,737 |
| | 2024 | 2020 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21NS113344 | Musashi1 and miR-137 antagonism: impact on neurogenesis and diseases | 000 | 1 | NIH | 11/29/2023 | $0 |
| | 2024 | 2019 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DE024797 | Bmp2 and Sost Genes and Their Interactions in Stem Cells of the Periodontium | 000 | 5 | NIH | 10/24/2023 | -$311 |
| | 2024 | 2019 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | TP1AH000206 | Replication of Programs Proven Effective throughout Bexar County and throughout Texas. | 02 | 2 | DHHS/OS | 11/28/2023 | $0 |
| | 2024 | 2018 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | RF1AG061872 | Identification of a missing key element underlying apoE2 neuroprotection in Alzheimer's disease and the aging brain | 000 | 1 | NIH | 10/1/2023 | -$4,572 |
| | 2024 | 2018 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | RF1AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 000 | 1 | NIH | 10/1/2023 | -$277,840 |
|
|
